Literature DB >> 8837221

Expression of pituitary adenylate cyclase activating peptide (PACAP) and PACAP type I receptors in the rat adrenal medulla.

K Moller1, F Sundler.   

Abstract

Pituitary adenylate cyclase activating polypeptide (PACAP) which belongs to the vasoactive intestinal polypeptide family of regulatory peptides, occurs in two variants, PACAP-27 and PACAP-38, and is thought to be an important messenger in both the central and peripheral nervous system. Three cloned G-protein coupled 7 transmembrane spanning receptors bind PACAP with high affinity, one reacting only weakly with VIP (PACAP type I receptor) the other two binding vasoactive intestinal peptide (VIP) with equally high affinity (VIP type I and II receptors). The PACAP type I receptor displays high affinity for both variants of PACAP. In this study, we have investigated the distribution of PACAP and the PACAP type I receptor in the adrenal medulla of newborn and adult rat. Immunocytochemistry revealed, in the adult rat, a dense network of PACAP-immunoreactive nerve fibers terminating on chromaffin cells. Such fibers were few and weakly immunoreactive in the newborn rat. PACAP-immunoreactive medullary cells could not be detected in the adult rat, whereas in the newborn, occasional cells were seen. By in situ-hybridization we detected PACAP type I receptor mRNA in a majority of the adrenal medullary cells of both newborn and adult rat. Receptor autoradiography using 125I-PACAP-27 as ligand revealed binding-sites with a localization virtually identical to the in situ hybridization signal indicating a functional expression of high-affinity type I PACAP receptors in the adrenal medulla. Additionally, in the adult rat, single or clustered large cells, presumably ganglion cells, contained an even higher abundance of PACAP receptor mRNA as well as binding sites than the surrounding chromaffin cells. Our observations on the distribution of PACAP peptide and PACAP receptors in the adrenal medulla suggest that both chromaffin cells and ganglion cells are PACAP targets. The data thus strengthen earlier observations indicating an important regulatory role of PACAP in catecholamine biosynthesis and release. The presence of both ligand and receptors in newborn rats may indicate a role for PACAP in the development of the adrenal medulla.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8837221     DOI: 10.1016/0167-0115(96)00033-x

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  11 in total

Review 1.  Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR review 1.

Authors:  Anthony J Harmar; Jan Fahrenkrug; Illana Gozes; Marc Laburthe; Victor May; Joseph R Pisegna; David Vaudry; Hubert Vaudry; James A Waschek; Sami I Said
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  Peptidergic activation of transcription and secretion in chromaffin cells. Cis and trans signaling determinants of pituitary adenylyl cyclase-activating polypeptide (PACAP).

Authors:  L Taupenot; S K Mahata; H Wu; D T O'Connor
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

Review 3.  PACAP: a master regulator of neuroendocrine stress circuits and the cellular stress response.

Authors:  Nikolas Stroth; Yvonne Holighaus; Djida Ait-Ali; Lee E Eiden
Journal:  Ann N Y Acad Sci       Date:  2011-03       Impact factor: 5.691

4.  Relationships between constitutive and acute gene regulation, and physiological and behavioral responses, mediated by the neuropeptide PACAP.

Authors:  Dana Bakalar; Sean Sweat; Gunner Drossel; Sunny Z Jiang; Babru B Samal; Nikolas Stroth; Wenqin Xu; Limei Zhang; Haiying Zhang; Lee E Eiden
Journal:  Psychoneuroendocrinology       Date:  2021-10-16       Impact factor: 4.905

5.  Pituitary adenylate cyclase-activating polypeptide (PACAP) induces relaxations of peripheral and cerebral arteries, which are differentially impaired by aging.

Authors:  Zoltan Vamos; Ivan Ivic; Peter Cseplo; Gabor Toth; Andrea Tamas; Dora Reglodi; Akos Koller
Journal:  J Mol Neurosci       Date:  2014-06-19       Impact factor: 3.444

6.  PACAP regulates immediate catecholamine release from adrenal chromaffin cells in an activity-dependent manner through a protein kinase C-dependent pathway.

Authors:  Barbara A Kuri; Shyue-An Chan; Corey B Smith
Journal:  J Neurochem       Date:  2009-06-05       Impact factor: 5.372

Review 7.  International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide.

Authors:  A J Harmar; A Arimura; I Gozes; L Journot; M Laburthe; J R Pisegna; S R Rawlings; P Robberecht; S I Said; S P Sreedharan; S A Wank; J A Waschek
Journal:  Pharmacol Rev       Date:  1998-06       Impact factor: 25.468

8.  Activated plasma coagulation β-Factor XII-induced vasoconstriction in rats.

Authors:  Peter C Papageorgiou; Erik L Yeo; Peter H Backx; John S Floras
Journal:  Clin Sci (Lond)       Date:  2012-06       Impact factor: 6.124

9.  Circulating PACAP peptide and PAC1R genotype as possible transdiagnostic biomarkers for anxiety disorders in women: a preliminary study.

Authors:  Rachel A Ross; Susanne S Hoeppner; Samantha N Hellberg; Emily B O'Day; Peter L Rosencrans; Kerry J Ressler; Víctor May; Naomi M Simon
Journal:  Neuropsychopharmacology       Date:  2020-01-07       Impact factor: 8.294

Review 10.  VIP/PACAP signaling as an alternative target during hyperoxic exposure in preterm newborns.

Authors:  Q Thaçi; S Reçica; I Kryeziu; V Mitrokhin; A Kamkin; R Sopi; N Hadzi-Petrushev; M Mladenov
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.